Tolerability of Postexposure Prophylaxis with Zidovudine, Lamivudine, and Nelfinavir for Human Immunodeficiency Virus Infection

Abstract
Tolerability of the combination of zidovudine, lamivudine, and nelfinavir used as postexposure prophylaxis (PEP) for HIV infection was prospectively